drugset / Trial / NCT02557594
Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This Phase I clinical study is to evaluate the safety and pharmacokinetics of DA-2802 319mg and Viread 300mg after a single oral dose in healthy male volunteers.
Timeline
- Start
- 2015-10-06
- Primary completion
- 2015-11-17
- Completion
- 2016-03-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-2802 | Unknown | 319 mg | Oral |
| Subject | Tenofovir disoproxil fumarate | Small molecule | 300 mg | Oral |
Indications
No indication recorded.